XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.70

+0.6%

9:56 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (10641)	7/7/1999 10:59:00 AM
From: aknahow	of 17367

Robert, you can parse this both ways. XOMA was clearly looking to do an I-Prex deal. They said so in print. What was done was a deal only to use rBPI21 in conjunction with other anti-infectives. Apparently the two parties could not agree to terms for the whole package. i am fine with that as I have maintained that partners are a necessary evil, so retaining the rights to anti-angiogenisis and whatever else I-Prex does is fine with me. Robert, obviously, what we say or do will not influence XOMA'S march to seek approval. What XOMA does on a financial basis does and will influence its' financial strength and this in turn can impact positively or negatively its' ability to move its' science forward. Do you know where the stock would be if XOMA had not cleared up the mortality target confusion? Neither of us will ever know, but I am less confident than you are that all would have been well, in this best of all possible worlds.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next